Latanoprost ophthalmic is used to treat glaucoma (a condition in which increased pressure in the eye can lead to gradual loss of vision) and ocular hypertension (a condition which causes increased pressure in the eye). Latanoprost is in a class of medications called prostaglandin analogs. It lowers pressure in the eye by increasing the flow of natural eye fluids out of the eye.
關(guān)鍵字： XALATAN; ISOPROPYL (5Z, 9A,11A,15R)-9,11,15-TRIHYDROXY-17-PHENYL-18,19,20-TRINOR-PROST-5Z-EN-1-OATE; 17-PHENYL-13,14-DIHYDRO TRINOR PROSTAGLANDIN F2ALPHA ISOPROPYL ESTER; 9ALPHA,11ALPHA,15R-TRIHYDROXY-17-PHENYL-18,19,20-TRINOR-PROST-5Z-EN-1-OIC ACID, ISOPROPYL ESTER; 9ALPHA, 11ALPHA, 15S-TRIHYDROXY-17-PHENYL-18,19,20-TRINOR-PROS-5Z-EN-1-OIC ACID, ISOPROPYL ESTER; (1r-(1-alpha(z),2-beta(r*),3-alpha,5-alpha))--methylethyleste; 7-(3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoicaci1; propan-2-yl.7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-pentyl)-cyclopentyl]hept-5-enoate; 1-methylet
鍶博睿創(chuàng)新團隊具有十二年的Ω系列脂肪酸的研發(fā)和生產(chǎn)經(jīng)驗，公司坐落于公家自主創(chuàng)新示范區(qū)武漢國家生物產(chǎn)業(yè)基地--光谷生物城，創(chuàng)始人及團隊2016年入選“3551光谷人才計劃”，2009年榮獲湖北省科技進步一等獎。目前脂肪酸領(lǐng)域主要是通過酯化、尿素包合并結(jié)合分子蒸餾技術(shù)實現(xiàn)產(chǎn)品的純化，我公司團隊創(chuàng)新性的利用特有生物酶技術(shù)攻克了Ω-3,6,7,9脂肪酸類成分分離、營養(yǎng)均衡等技術(shù)的世界難題。既保證了天然油脂的生物活性，有保證了其來源的天然性、產(chǎn)品使用的穩(wěn)定性，在同類產(chǎn)品中高端市場國際占有率瑤瑤領(lǐng)先，鍶博睿勵志成為天然脂肪酸高端領(lǐng)域的先行者。